Tamaki, Chihiro
Eli Lilly (Japan) · Japan Pharmaceutical Manufacturers Association
3 papers on CoChat
Most cited papers
- Verified
Major Involvement of Low-Density Lipoprotein Receptor-Related Protein 1 in the Clearance of Plasma Free Amyloid β-Peptide by the Liver
Tamaki, C., Ohtsuki, S., Iwatsubo, T., Hashimoto, T., Yamada, K., Yabuki, C., & Terasaki, T. (2006) · Pharmaceutical Research
Alzheimer's disease research and treatmentsCholesterol and Lipid Metabolism
Cited by 119
- Verified
Insulin Facilitates the Hepatic Clearance of Plasma Amyloid β-Peptide (1–40) by Intracellular Translocation of Low-Density Lipoprotein Receptor-Related Protein 1 (LRP-1) to the Plasma Membrane in Hepatocytes
Tamaki, C., Ohtsuki, S., & Terasaki, T. (2007) · Molecular Pharmacology
Alzheimer's disease research and treatmentsCholesterol and Lipid Metabolism
Cited by 111
- Verified
Potentials and limitations of nonclinical safety assessment for predicting clinical adverse drug reactions: correlation analysis of 142 approved drugs in Japan
Tamaki, C., Nagayama, T., Hashiba, M., Fujiyoshi, M., Hizue, M., Kodaira, H., Nishida, M., Suzuki, K., Takashima, Y., Ogino, Y., et al. (2013) · The Journal of Toxicological Sciences
Animal testing and alternativesPharmacovigilance and Adverse Drug Reactions
Cited by 79
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free